Members

  First name: Cédric
  Last name: Laouénan
  Position: Professor (PU-PH) of biostatistics
  Email: cedric.laouenan
._
_.
inserm.fr

Research interest


Modeling of infectious diseases and comparison of clinical trial designs in an epidemic context of emerging infectious diseases

Education

Degree

2022: Habilitation à Diriger des Recherches, Université Paris Cité
2014: PhD in biostatistics, Université Paris Diderot, France
2009: MD – Specialization in Public Health, Université de Rouen, France
2008: MSc Public Health – Specialization in statistical genetics, Université Paris Sud, France


Academic positions

2023-present: Professor of biostatistics, Université Paris Cité / Département d’Epidémiologie Biostatistique et Recherche Clinique – Hôpital Bichat, AP-HP.Nord, Paris, France

2015-2023: Associate Professor in biostatistics, Université Paris Cité / Département d’Epidémiologie Biostatistique et Recherche Clinique – Hôpital Bichat, AP-HP.Nord, Paris, France

2009/13: Assistant Professor in biostatistics, Paris Diderot University and biostatistics department – Paris Nord Val-de-Seine University Hospital, AP-HP, France


Research training (post doctoral)

Co-Head of axis 3 « Clinical trial methodology and investigations in severe or emerging infectious diseases » in the BIPID team

Exhaustive list of publications

2024


Castera L, Garteiser P, Laouenan C, Vidal-Trécan T, Vallet-Pichard A, Manchon P, Paradis V, Czernichow S, Roulot D, Larger E, Pol S, Bedossa P, Correas JM, Valla D, Gautier JF, Van Beers BE, QUID NASH investigators
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes.
Journal of Hepatology 2024, S0168-8278(24)00206-X.

Sokal A, Royer G, Esposito-Farese M, Clermont O, Condamine B, Laouénan C, Lefort A, Denamur E, de Lastours V, Colibafi, Septicoli and Coliville Groups
Clinical and bacteriological specificities of Escherichia coli bloodstream infections from biliary portal of entries.
The Journal of Infectious Diseases 2024, jiad586.

Gaillard F, Bachelet D, Couchoud C, Laouenan C, Peoc'h K, Simon Q, Charles N, Jourde-Chiche N, Daugas E
Lupus activity and outcomes in lupus patients undergoing maintenance dialysis.
Rheumatology (Oxford, England) 2024, 63, 780-786.

2023


Gault N, Bachelet D, Laouénan C, Borie R, Cracowski C, Poissy J, Faure K, Lainé F, Lefèvre B, Isnard M, Patrier J, Launay O, Costagliola D, Ghosn J, Bouadma L, French COVID Cohort Study Group and The French COVID Investigators Study Group
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
Journal of Medical Virology 2023, 95, e28819.

Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal of Medical Virology 2023, 95, e29247.

Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R, French COVID cohort study group, Lévy Y
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Journal of Clinical Immunology 2023, 43, 882-893.

Ghosn J, Bachelet D, Livrozet M, Cervantes-Gonzalez M, Poissy J, Goehringer F, Gandonniere CS, Maillet M, Bani-Sadr F, Martin-Blondel G, Tattevin P, Launay O, Surgers L, Dudoignon E, Liegeon G, Zucman D, Joseph C, Senneville E, Yelnik C, Roger PM, Faure K, Gousseff M, Cabié A, Duval X, Chirouze C, Laouénan C, French COVID cohort Study Group and the French COVID cohort Investigators Group
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2023, 29, 254.e7-254.e13.

Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, Palacios Baena ZR, Rossi E, Hasenauer J, Lopes-Rafegas I, Righi E, Caroccia N, Cataudella S, Pasquini Z, Osmo T, Del Piccolo L, Savoldi A, Kumar-Singh S, Mazzaferri F, Caponcello MG, de Boer G, Hara GL, ORCHESTRA Study Group, De Nardo P, Malhotra S, Canziani LM, Ghosn J, Florence AM, Lafhej N, van der Gun BTF, Giannella M, Laouénan C, Tacconelli E
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
EClinicalMedicine 2023, 62, 102107.

Le Guen P, Tardivon C, Laouénan C, Debray MP, Nicaise Roland P, Taillé C, Borie R, Ottaviani S, Guenther A, Dieudé P, Crestani B
Anti-mutated citrullinated vimentin antibodies are increased in IPF patients.
Respiratory Medicine and Research 2023, 85, 101081.

de Roquetaillade C, Laouenan C, Mira JP, Roy C, Thuong M, Azoulay É, Gruson D, Jacobs F, Chommeloux J, Raffi F, Hocqueloux L, Imbert P, Jeantils V, Delassus JL, Matheron S, Fitting C, Timsit JF, Bruneel F
Cytokine profiles in adults with imported malaria.
Scientific Reports 2023, 13, 10347.

Kartsonaki C, Baillie JK, Barrio NG, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Elotmani L, Escher M, Farshait N, Goffard JC, Gonçalves BP, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov NA, Nichol AD, Singh Oinam BC, Ong D, Panda PK, Petrovic M, Pritchard MG, Ramakrishnan N, Ramos GV, Roger C, Sandulescu O, Semple MG, Sharma P, Sigfrid L, Somers EC, Streinu-Cercel A, Taccone F, Vecham PK, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils EJ, Ci Wong X, Horby P, Rojek A, Olliaro PL, ISARIC Clinical Characterisation Group
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
International Journal of Epidemiology 2023, 52, 355-376.

Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K, COVID HGE Consortium, French COVID Study Group, COMET Consortium, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science Immunology 2023, 8, eabp8966.

Philippot Q, Bastard P, Puel A, Casanova JL, Cobat A, Laouénan C, Tardivon C, Crestani B, Borie R
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.
Respiratory Research 2023, 24, 87.

Pesonel E, Hoffmann I, Guiraud L, Bourner J, Diallo A, Dunning J, Horby P, Kali S, Laouénan C, Mentré F, Merson L, Molino D, Palich R, Rojek A, Tacconelli E, Tardivon C, MOSAIC study group, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P
MOSAIC: A cohort study of human mpox virus disease.
Wellcome Open Research 2023, 8, 415.

Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX
[MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks].
Virologie (Montrouge, France) 2023, 27, 23-26.

Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Virologie (Montrouge, France) 2023, 27, 12-15.

Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B, Bihan H, Julla JB, Radu A, Poynard T, Brzustowsky A, Larger E, Czernichow S, Pol S, Bedossa P, Valla D, Gautier JF, QUID-NASH investigators
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold.
Diabetes Care 2023, 46, 1354-1362.

Azzini AM, Canziani LM, Davis RJ, Mirandola M, Hoelscher M, Meyer L, Laouénan C, Giannella M, Rodríguez-Baño J, Boffetta P, Mates D, Malhotra-Kumar S, Scipione G, Stellmach C, Rinaldi E, Hasenauer J, Tacconelli E
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2.
Vaccines 2023, 11, 1361.

2022


Karila-Cohen P, Pelletier AL, Saker L, Laouénan C, Bachelet D, Khalil A, Arapis K
Staple Line Intrathoracic Migration After Sleeve Gastrectomy: Correlation between Symptoms, CT Three-Dimensional Stomach Analysis, and 24-h pH Monitoring.
Obesity Surgery 2022, 32, 1-9.

Eloy P, Laouénan C, Beavogui AH, Keita S, Manchon P, Etard JF, Sissoko D, Mentré F, Malvy D
High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea.
IDCases 2022, 27, e01412.

Méchaï F, Bachelet D, Han L, Dubert M, Parisey M, Cordel H, Bourgarit A, Bertrac C, Chauveau S, Billard-Pomares T, Carbonnelle E, Bouchaud O, Yazdanpanah Y, Vignier N, Laouénan C
Tuberculosis treatment outcomes among precarious patients in France.
Infectious Diseases Now 2022, 52, 389-395.

Royer G, Clermont O, Condamine B, Mercier-Darty M, Laouénan C, Lefort A, Denamur E, de Lastours V, COLIBAFI and SEPTICOLI Groups
O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, 74, 364-366.

De Castro N, Mechaï F, Bachelet D, Canestri A, Joly V, Vandenhende M, Boutoille D, Kerjouan M, Veziris N, Molina JM, Grall N, Tattevin P, Laouénan C, Yazdanpanah Y, FAST TB Study Group
Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).
Open Forum Infectious Diseases 2022, 9, ofac353.

David C, Duployez N, Eloy P, Belhadi D, Chezel J, Guern VL, Laouénan C, Fenwarth L, Rouzaud D, Mathian A, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Preudhomme C, Costedoat-Chalumeau N, Sacre K
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
Rheumatology (Oxford, England) 2022, 61, 4355-4363.

David C, Costedoat-Chalumeau N, Belhadi D, Laouénan C, Boutten A, Chezel J, Rouzaud D, Dehoux M, Guern VL, Mathian A, Chaves SdA, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Sacre K
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study.
Journal of Internal Medicine 2022, 292, 536-539.

Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.
BMJ medicine 2022, 1, e000093.

Morvillers JM, Roy C, Laouénan C, Goutté N
[Therapeutic alliance between sectorial psychiatry inpatients and nurses and aides: A prospective, observational and cross-sectional study].
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie 2022, 67, 854-863.

Dauriat G, Reynaud-Gaubert M, Cottin V, Lamia B, Montani D, Belhadi D, Humbert M, Laouenan C, Mal H, French group of investigators on severe PH-COPD
Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort.
The European Respiratory Journal 2022, 60, 2102897.

Denamur E, Condamine B, Esposito-Farèse M, Royer G, Clermont O, Laouenan C, Lefort A, de Lastours V, Galardini M, COLIBAFI, SEPTICOLI groups
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
PLoS genetics 2022, 18, e1010112.

Belhadi D, El Baied M, Mulier G, Malvy D, Mentré F, Laouénan C
The number of cases, mortality and treatments of viral hemorrhagic fevers: A systematic review.
PLoS neglected tropical diseases 2022, 16, e0010889.

2021


Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C, French COVID cohort study and investigators groups
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1041.e1-1041.e4.

Dauriat G, Reynaud-Gaubert M, Cottin V, Lamia B, Montani D, Canuet M, Boissin C, Tromeur C, Chaouat A, Degano B, Bergot E, Sanchez O, Prevot G, Sitbon O, Thabut G, Belhadi D, de Beauregard YC, Bencherif A, Humbert M, Simonneau G, Laouenan C, Mal H
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 2021, 40, 1009-1018.

Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Turnier PL, Marechal ML, Cabié A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laouénan C, Etienne M, Nguyen D, Ghosn J, Duval X, French COVID cohort study and investigators groups
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2021, 112, 247-253.

Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R, French COVID cohort study group
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience 2021, 24, 102711.

Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouénan C, Ghosn J, Fenwick C, Comte D, Roger T, Regina J, Vollenweider P, Waeber G, Oddo M, Calandra T, Pantaleo G
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Nature Communications 2021, 12, 4888.

Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proceedings of the National Academy of Sciences of the United States of America 2021, 118,

Duval X, Le Moing V, Tubiana S, Esposito-Farèse M, Ilic-Habensus E, Leclercq F, Bourdon A, Goehringer F, Selton-Suty C, Chevalier E, Boutoille D, Piriou N, Le Tourneau T, Chirouze C, Seronde MF, Morel O, Piroth L, Eicher JC, Humbert O, Revest M, Thébault E, Devillers A, Delahaye F, Boibieux A, Grégoire B, Hoen B, Laouenan C, Iung B, Rouzet F, AEPEI-TEPvENDO study group
Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2021, 73, 393-403.

Chezel J, Costedoat-Chalumeau N, Laouénan C, Rouzaud D, Chenevier-Gobeaux C, Le Guern V, Mathian A, Belhadi D, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Saidoune F, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Sacre K
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).
Rheumatology (Oxford, England) 2021, 60, 1210-1215.

Poynard T, Paradis V, Mullaert J, Deckmyn O, Gault N, Marcault E, Manchon P, Si Mohammed N, Parfait B, Ibberson M, Gautier JF, Boitard C, Czernichow S, Larger E, Drane F, Castille JM, Peta V, Brzustowski A, Terris B, Vallet-Pichard A, Roulot D, Laouénan C, Bedossa P, Castera L, Pol S, Valla D, Quid-Nash consortium
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.
Alimentary Pharmacology & Therapeutics 2021, 54, 952-966.

Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E, French-Covid cohort investigators and study group
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.
Fundamental & Clinical Pharmacology 2021

Manchon P, Belhadi D, Mentré F, Laouénan C
Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
BMC medical research methodology 2021, 21, 98.

Royer G, Darty MM, Clermont O, Condamine B, Laouenan C, Decousser JW, Vallenet D, Lefort A, de Lastours V, Denamur E, COLIBAFI and SEPTICOLI groups
Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.
Genome Medicine 2021, 13, 77.

Curlier E, Fagour L, Herrmann-Storck C, Staelen A, Vingadassalom I, Breurec S, Abel S, Pierre-François S, Jean-Marie J, Laouénan C, Césaire R, Hoen B, Cabié A
Seroprevalence of chikungunya virus infection among HIV-infected adults in French Caribbean Islands of Martinique and Guadeloupe in 2015: A cross-sectional study.
PLoS neglected tropical diseases 2021, 15, e0009267.

Périllaud-Dubois C, Belhadi D, Laouénan C, Mandelbrot L, Picone O, Vauloup-Fellous C
Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review.
PloS One 2021, 16, e0261011.

Sarda-Mantel L, Kaoutar J, Alfaiate T, Lopes A, Paycha F, Benali K, Mikail N, Soussan M, Lemarignier C, Méchaï F, Nagat SL, Montravers F, Deradji O, Durand E, Goulenok T, Ponscarme D, Yéni P, Laouénan C, Rioux C
[ 18 F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis.
Frontiers in Medicine 2021, 8, 715115.

2020


Madelain V, Mentré F, Baize S, Anglaret X, Laouénan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Günther S, Raoul H, de Lamballerie X, Guedj J
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
CPT: pharmacometrics & systems pharmacology 2020, 9, 258-271.

Pelletier AL, Boukris A, Karunakaran S, Dib F, Laouénan C, Hansel B, Arapis K, Abramowitz L
A prospective study of anal symptoms and continence among obese patients before and after bariatric surgery.
Techniques in Coloproctology 2020, 24, 1263-1269.

Hyafil F, Chequer R, Sorbets E, Estellat C, Ducrocq G, Rouzet F, Alfaiate T, Regaieg H, Abtan J, Leygnac S, Milliner M, Imbert L, Burg S, Ben Azzouna R, Potier L, Laouénan C, Quintin C, Roussel R, Hartemann A, Montalescot G, Marie PY, Steg G, Le Guludec D
Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individuals.
Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2020, 27, 755-768.

Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S, ESCMID Study Group for Respiratory Viruses
Review of trials currently testing treatment and prevention of COVID-19.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 988-998.

Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, Choquet C, Timsit JF, Ghosn J, Charpentier C, Descamps D, Houhou-Fidouh N, French COVID cohort management committee, CoV-CONTACT study group, members of the French-COVID cohort study group (by alphabetical order), member of the CoV-CONTACT study group. Principal investigator, Steering Committee, CoV-CONTACT Clinical Centers, Coordination and statistical analyses, Virological Lab, Biological Center, Partners, Sponsor, Genetic
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, S1198-743X(20)30721-7.

Giannelli V, Roux O, Laouénan C, Manchon P, Ausloos F, Bachelet D, Rautou PE, Weiss E, Moreau R, Mebazaa A, Cohen-Solal A, Durand F, Francoz C
Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
Journal of Hepatology 2020, 72, 463-471.

Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E
Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
AIDS care 2020, 32, 811-817.

Stegmann-Planchard S, Gallian P, Tressières B, Leparc-Goffart I, Lannuzel A, Signaté A, Laouénan C, Cabié A, Hoen B
Chikungunya, a Risk Factor for Guillain-Barré Syndrome.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020, 70, 1233-1235.

de Lastours V, Laouénan C, Royer G, Carbonnelle E, Lepeule R, Esposito-Farèse M, Clermont O, Duval X, Fantin B, Mentré F, Decousser JW, Denamur E, Lefort A
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2334-2343.

Lê MP, Jaquet P, Patrier J, Wicky PH, Le Hingrat Q, Veyrier M, Kauv J, Sonneville R, Visseaux B, Laouénan C, Bouadma L, Descamps D, de Montmollin E, Peytavin G, Timsit JF
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2657-2660.

Halfon M, Bachelet D, Hanouna G, Dema B, Pellefigues C, Manchon P, Laouenan C, Charles N, Daugas E
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2020

Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Rodríguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C, COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, NIAID-USUHS/TAGC COVID Immunity Group, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science (New York, N.Y.) 2020, 370,

Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Science Translational Medicine 2020, 12,

Goulas A, Belhadi D, Descamps A, Andremont A, Benoit P, Courtois S, Dagot C, Grall N, Makowski D, Nazaret S, Nelieu S, Patureau D, Petit F, Roose-Amsaleg C, Vittecoq M, Livoreil B, Laouenan C
How effective are strategies to control the dissemination of antibiotic resistance in the environment? A systematic review.
Environmental Evidence 2020, 9, 4.

Lilamand M, Saintout M, Vigan M, Bichon A, Tourame L, Diet AB, Iung B, Himbert D, Laouenan C, Raynaud-Simon A
Quality of life, physical performance and nutritional status in older patients hospitalized in a cardiology department.
Journal of geriatric cardiology: JGC 2020, 17, 410-416.

Bertolotti A, Thioune M, Abel S, Belrose G, Calmont I, Césaire R, Cervantes M, Fagour L, Javelle É, Lebris C, Najioullah F, Pierre-François S, Rozé B, Vigan M, Laouénan C, Cabié A, Chronic Chikungunya working group of University Medical Center of Martinique
Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): A prospective cohort study.
PLoS neglected tropical diseases 2020, 14, e0007327.

2019


Nicolas-Chanoine MH, Vigan M, Laouénan C, Robert J, “E-carb Study Group”
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019, 38, 383-393.

Maataoui N, Mayet A, Duron S, Delacour H, Mentré F, Laouenan C, Desvillechabrol D, Cokelaer T, Meynard JB, Ducher A, Andremont A, Armand-Lefèvre L, Mérens A
High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 631.e1-631.e9.

Cousien A, Abel S, Monthieux A, Andronico A, Calmont I, Cervantes M, Césaire R, Gallian P, de Lamballerie X, Laouénan C, Najioullah F, Pierre-François S, Pircher M, Salje H, Ten Bosch QA, Cabié A, Cauchemez S
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016.
American Journal of Epidemiology 2019, 188, 1389-1396.

Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P
Metabolic syndrome and endocrine status in HIV-infected transwomen.
AIDS (London, England) 2019, 33, 855-865.

Calais J, Touati A, Grall N, Laouénan C, Benali K, Mahida B, Vigne J, Hyafil F, Iung B, Duval X, Lepage L, Le Guludec D, Rouzet F
Diagnostic Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and White Blood Cell SPECT/Computed Tomography in Patients With Suspected Cardiac Implantable Electronic Device Chronic Infection.
Circulation. Cardiovascular Imaging 2019, 12, e007188.

Reynard S, Journeaux A, Gloaguen E, Schaeffer J, Varet H, Pietrosemoli N, Mateo M, Baillet N, Laouenan C, Raoul H, Mullaert J, Baize S
Immune parameters and outcomes during Ebola virus disease.
JCI insight 2019, 4, 125106.

2018


Payancé A, Silva-Junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández-Gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia-Pagan JC, Rautou PE
Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis.
Hepatology (Baltimore, Md.) 2018, 68, 1508-1518.

Ambert-Dahan E, Laouenan C, Lebredonchel M, Borel S, Carillo C, Bouccara D, Sterkers O, Ferrary E, Mosnier I
Evaluation of the impact of hearing loss in adults: Validation of a quality of life questionnaire.
Eur Ann Otorhinolaryngol Head Neck Dis 2018, 135, 25-31.

Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabie A, Callier C, Carles G, Cassadou S, Cesaire R, Douine M, Herrmann-Storck C, Kadhel P, Laouenan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressieres B, Volumenie JL, Yassinguezo S, Janky E, Fontanet A
Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.
N Engl J Med 2018, 378, 985-994.

Mawet J, Valade D, Vigan M, Laouenan C, Roos C
Oxygen delivered by a high flow concentrator for the treatment of medication-overuse headache: A prospective open-labeled pilot feasibility study.
Cephalalgia Reports 2018, 1, 2515816318810196.

Goulas A, Livoreil B, Grall N, Benoit P, Couderc-Obert C, Dagot C, Patureau D, Petit F, Laouénan C, Andremont A
What are the effective solutions to control the dissemination of antibiotic resistance in the environment? A systematic review protocol.
Environmental Evidence 2018, 7, 3.

Rasigade JP, Leclère A, Alla F, Tessier A, Bes M, Lechiche C, Vernet-Garnier V, Laouénan C, Vandenesch F, Leport C, AEPEI Study Group
Staphylococcus aureus CC30 Lineage and Absence of sed,j,r-Harboring Plasmid Predict Embolism in Infective Endocarditis.
Frontiers in Cellular and Infection Microbiology 2018, 8, 187.

2017


Grall N, Lazarevic V, Gaia N, Couffignal C, Laouenan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J
Unexpected persistence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.
Int J Antimicrob Agents 2017, 50, 81-87.

Nguyen TH, Guedj J, Anglaret X, Laouenan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentre F
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.
PLoS Negl Trop Dis 2017, 11, e0005389.

2016


Aubin-Auger I, Laouenan C, Le Bel J, Mercier A, Baruch D, Lebeau JP, Youssefian A, Le Trung T, Peremans L, Van Royen P
Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial.
Eur J Cancer Care (Engl) 2016, 25, 18-26.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JIKI Study Group
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.

2015


Laouenan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hezode C, Carrat F, Nicot F, Marcellin P, Mentre F
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
CPT Pharmacometrics Syst Pharmacol 2015, 4, e00008.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F
Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.
European Journal of Clinical Pharmacology 2015, 71, 75–83.

Ladjeroud S, Touraine S, Laouénan C, Parlier-Cuau C, Bousson V, Laredo JD
Impact of osteoid osteomas of the hip on the size and fatty infiltration of the thigh muscles.
Clinical Imaging 2015, 39, 128–132.

Maubec E, Laouénan C, Deschamps L, Nguyen VT, Scheer-Senyarich I, Wackenheim-Jacobs AC, Steff M, Duhamel S, Tubiana S, Brahimi N, Leclerc-Mercier S, Crickx B, Perret C, Aractingi S, Escoubet B, Duval X, Arnaud P, Jaisser F, Mentré F, Farman N
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
The Journal of Investigative Dermatology 2015, 135, 1781–1789.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1487–1494.

Lapalus M, Laouenan C, Cardoso AC, Estrabaud E, Carvalho-Filho RJ, Zhang Q, Lada O, Appourchaux K, Mouri F, Boyer N, Bedossa P, Asselah T, Martinot-Peignoux M, Marcellin P
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 2082–2089.

Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E
Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.
International journal of STD & AIDS 2015, 26, 33-36.

Guglielminotti J, Dechartres A, Mentré F, Montravers P, Longrois D, Laouénan C
Reporting and Methodology of Multivariable Analyses in Prognostic Observational Studies Published in 4 Anesthesiology Journals: A Methodological Descriptive Review.
Anesthesia and Analgesia 2015, 121, 1011–1029.

Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Infectious Diseases (London, England) 2015, 47, 725-731.

Blanchon T, Geffrier F, Turbelin C, Daviaud I, Laouénan C, Duval X, Lambert B, Hanslik T, Mosnier A, Leport C
Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013.
Antiviral Therapy 2015, 20, 753–761.

2014


Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
Journal of Hepatology 2014, 60, 1151–1157.

Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, Laouénan C, Montravers P
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*.
Critical Care Medicine 2014, 42, 1150-1156.

Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E, COLIBAFI Group
Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.
The Pediatric Infectious Disease Journal 2014, 33, 872–879.

Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E, COLIBAFI Group
Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1035–1041.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L
Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.
British Journal of Clinical Pharmacology 2014, 78, 1022–1034.

Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Journal of Viral Hepatitis 2014, 21, 525–532.

Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.

Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M, FRANCE 2 Investigators
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score.
Heart (British Cardiac Society) 2014, 100, 1016–1023.

Amarenco P, Davis S, Jones EF, Cohen AA, Heiss WD, Kaste M, Laouénan C, Young D, Macleod M, Donnan GA, Aortic Arch Related Cerebral Hazard Trial Investigators
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Stroke 2014, 45, 1248–1257.

Konofal E, Zhao W, Laouénan C, Lecendreux M, Kaguelidou F, Benadjaoud L, Mentré F, Jacqz-Aigrain E
Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.
Drug Design, Development and Therapy 2014, 8, 2321–2332.

Abramowitz L, Benabderrahmane M, Pospait D, Philip J, Laouénan C
The prevalence of proctological symptoms amongst patients who see general practitioners in France.
The European Journal of General Practice 2014, 20, 301–306.

2013


Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso ACF, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 401–407.

Séroussi B, Laouénan C, Gligorov J, Uzan S, Mentré F, Bouaud J
Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?.
British Journal of Cancer 2013, 109, 1147–1156.

Bleibtreu A, Gros PA, Laouénan C, Clermont O, Le Nagard H, Picard B, Tenaillon O, Denamur E
Fitness, stress resistance, and extraintestinal virulence in Escherichia coli.
Infection and Immunity 2013, 81, 2733–2742.

Escoubet B, Couffignal C, Laisy JP, Mangin L, Chillon S, Laouénan C, Serfaty JM, Jeunemaitre X, Mentré F, Zennaro MC
Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
Circulation. Cardiovascular Genetics 2013, 6, 381–390.

Laouénan C, Guedj J, Mentré F
Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.
BMC medical research methodology 2013, 13, 60.

Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O, Vihvo Study Group
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.
HIV clinical trials 2013, 14, 313-318.

Nicolas-Chanoine MH, Robert J, Vigan M, Laouenan C, Brisse S, Mentre F, Jarlier V
Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates.
PLoS One 2013, 8, e72191.

2012


Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2012, 53, 43–47.

Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2231-2235.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH, Coli β Study Group
Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Journal of Clinical Microbiology 2012, 50, 2974–2981.

Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Michel PL, Mentré F, Vahanian A
Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients.
Circulation 2012, 125, 2119–2127.

Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F, Group Coli β
Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.
PloS One 2012, 7, e30498.

Lucet JC, Laouenan C, Chelius G, Veziris N, Lepelletier D, Friggeri A, Abiteboul D, Bouvet E, Mentre F, Fleury E
Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions.
PloS One 2012, 7, e37893.

Séroussi B, Soulet A, Messai N, Laouénan C, Mentré F, Bouaud J
Patient clinical profiles associated with physician non-compliance despite the use of a guideline-based decision support system: a case study with OncoDoc2 using data mining techniques.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2012, 2012, 828–837.

2009


Laouénan C, Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Abdel-Hamid M, Rekacewicz C, Obach D, Fontanet A, Abel L
Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions.
Human Genetics 2009, 126, 697-705.

2008


Tavolacci MP, Laouenan C, Ladner J
What access and use of Internet technology for undergraduate medical students?.
Medical Teacher 2008, 30, 223-224.